The orphan nuclear receptor Rev-Erbα is a peroxisome proliferator-activated receptor (PPAR) γ target gene and promotes PPAR γ-induced adipocyte differentiation

被引:199
|
作者
Fontaine, C
Dubois, G
Duguay, Y
Helledie, T
Vu-Dac, N
Gervois, P
Soncin, F
Mandrup, S
Fruchart, JC
Fruchart-Najib, J
Staels, B
机构
[1] Inst Pasteur, INSERM, UR545, Dept Atherosclerose, F-59019 Lille, France
[2] Univ Lille 2, Fac Pharm, F-59006 Lille, France
[3] Inst Biol Lille, F-59021 Lille, France
[4] Univ So Odense, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark
关键词
D O I
10.1074/jbc.M304664200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rev-Erbalpha (NR1D1) is an orphan nuclear receptor encoded on the opposite strand of the thyroid receptor alpha gene. Rev-Erbalpha mRNA is induced during adipocyte differentiation of 3T3-L1 cells, and its expression is abundant in rat adipose tissue. Peroxisome proliferator-activated receptor gamma (PPARgamma) (NR1C3) is a nuclear receptor controlling adipocyte differentiation and insulin sensitivity. Here we show that Rev-Erbalpha expression is induced by PPARgamma activation with rosiglitazone in rat epididymal and perirenal adipose tissues in vivo as well as in 3T3-L1 adipocytes in vitro. Furthermore, activated PPARgamma induces Rev-Erbalpha promoter activity by binding to the direct repeat (DR)-2 response element Rev-DR2. Mutations of the 5' or 3' half-sites of the response element totally abrogated PPARgamma binding and transcriptional activation, identifying this site as a novel type of functional PPARgamma response element. Finally, ectopic expression of Rev-Erbalpha in 3T3-L1 preadipocytes potentiated adipocyte differentiation induced by the PPARgamma ligand rosiglitazone. These results identify Rev-Erbalpha as a target gene of PPARgamma in adipose tissue and demonstrate a role for this nuclear receptor as a promoter of adipocyte differentiation.
引用
收藏
页码:37672 / 37680
页数:9
相关论文
共 50 条
  • [21] Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis
    Harslof, T.
    Tofteng, C. L.
    Husted, L. B.
    Nyegaard, M.
    Borglum, A.
    Carstens, M.
    Stenkjaer, L.
    Brixen, K.
    Eiken, P.
    Jensen, J-E B.
    Mosekilde, L.
    Rejnmark, L.
    Langdahl, B. L.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (10) : 2655 - 2666
  • [22] Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis
    Muruganandan, Shanmugam
    Parlee, Sebastian D.
    Rourke, Jillian L.
    Ernst, Matthew C.
    Goralski, Kerry B.
    Sinal, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (27) : 23982 - 23995
  • [23] Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein
    Dang, ZC
    Audinot, V
    Papapoulos, SE
    Boutin, JA
    Löwik, CWGM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) : 962 - 967
  • [24] Peroxisome proliferator-activated receptor (PPAR)-β/δ stimulates differentiation and lipid accumulation in keratinocytes
    Schmuth, M
    Haqq, CM
    Cairns, WJ
    Holder, JC
    Dorsam, S
    Chang, S
    Lau, P
    Fowler, AJ
    Chuang, G
    Moser, AH
    Brown, BE
    Man, MQ
    Uchida, Y
    Schoonjans, K
    Auwerx, J
    Chambon, R
    Willson, TM
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (04) : 971 - 983
  • [25] Peroxisome Proliferator-Activated Receptor (PPAR)-β as a Target for Wound Healing DrugsWhat is Possible?
    Nguan Soon Tan
    Liliane Michalik
    Beatrice Desvergne
    Walter Wahli
    American Journal of Clinical Dermatology, 2003, 4 : 523 - 530
  • [26] Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer
    Matthew R. Smith
    Philip W. Kantoff
    Investigational New Drugs, 2002, 20 : 195 - 200
  • [27] Peroxisome proliferator-activated receptor gamma (PPARγ) as a novel target for prostate cancer
    Smith, MR
    Kantoff, PW
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (02) : 195 - 200
  • [28] Epidermal peroxisome proliferator-activated receptor gamma (PPARγ) as a target for UVB radiation
    Zhang, Q
    Konger, R
    Travers, JB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A141 - A141
  • [29] The insulin receptor:: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione-PPARγ agonists
    Costa, V.
    Foti, D.
    Paonessa, F.
    Chietari, E.
    Palaia, L.
    Brunetti, G.
    Gulletta, E.
    Fusco, A.
    Brunetti, A.
    ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 325 - 335
  • [30] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION
    CHAWLA, A
    SCHWARZ, EJ
    DIMACULANGAN, DD
    LAZAR, MA
    ENDOCRINOLOGY, 1994, 135 (02) : 798 - 800